BioLife Solutions, Inc. (BLFS)
35.93
+0.46
(+1.30%)
USD |
NASDAQ |
Sep 02, 16:00
35.93
0.00 (0.00%)
After-Hours: 20:00
BioLife Solutions Research and Development Expense (TTM) : 8.25M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.25M |
| March 31, 2026 | 7.257M |
| December 31, 2025 | 6.046M |
| September 30, 2025 | 7.296M |
| June 30, 2025 | 6.48M |
| March 31, 2025 | 6.544M |
| December 31, 2024 | 7.18M |
| September 30, 2024 | 9.057M |
| June 30, 2024 | 10.90M |
| March 31, 2024 | 12.67M |
| December 31, 2023 | 14.74M |
| September 30, 2023 | 15.85M |
| June 30, 2023 | 15.53M |
| March 31, 2023 | 15.17M |
| December 31, 2022 | 14.80M |
| September 30, 2022 | 14.20M |
| June 30, 2022 | 14.00M |
| March 31, 2022 | 13.62M |
| December 31, 2021 | 11.82M |
| September 30, 2021 | 10.10M |
| June 30, 2021 | 8.611M |
| March 31, 2021 | 7.043M |
| December 31, 2020 | 6.719M |
| September 30, 2020 | 5.613M |
| June 30, 2020 | 4.92M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.134M |
| December 31, 2019 | 2.83M |
| September 30, 2019 | 2.397M |
| June 30, 2019 | 1.677M |
| March 31, 2019 | 1.311M |
| December 31, 2018 | 1.298M |
| September 30, 2018 | 1.278M |
| June 30, 2018 | 1.259M |
| March 31, 2018 | 1.253M |
| December 31, 2017 | 1.194M |
| September 30, 2017 | 1.326M |
| June 30, 2017 | 1.530M |
| March 31, 2017 | 1.811M |
| December 31, 2016 | 2.028M |
| September 30, 2016 | 2.026M |
| June 30, 2016 | 1.859M |
| March 31, 2016 | 1.561M |
| December 31, 2015 | 1.379M |
| September 30, 2015 | 1.311M |
| June 30, 2015 | 1.134M |
| March 31, 2015 | 1.026M |
| December 31, 2014 | 0.8711M |
| September 30, 2014 | 0.6398M |
| June 30, 2014 | 0.647M |
| March 31, 2014 | 0.5491M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Repligen Corp. | 55.23M |
| Agilent Technologies, Inc. | 480.00M |
| Danaher Corp. | 1.615B |
| Thermo Fisher Scientific, Inc. | 1.403B |
| West Pharmaceutical Services, Inc. | 74.40M |